Sanofi Share Price

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris 16:37:15 30/05/2024 BST 5-day change 1st Jan Change
88.57 EUR +0.98% Intraday chart for Sanofi -1.76% -1.33%

Financials

Sales 2024 * 46.28B 50.07B 3,936B Sales 2025 * 49.84B 53.92B 4,238B Capitalization 111B 120B 9,416B
Net income 2024 * 7.08B 7.66B 602B Net income 2025 * 8.69B 9.4B 739B EV / Sales 2024 * 2.54 x
Net Debt 2024 * 6.69B 7.24B 569B Net Debt 2025 * 2.29B 2.48B 195B EV / Sales 2025 * 2.27 x
P/E ratio 2024 *
15.9 x
P/E ratio 2025 *
12.8 x
Employees 86,088
Yield 2024 *
4.37%
Yield 2025 *
4.6%
Free-Float 87.13%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.98%
1 week-1.76%
Current month-4.85%
1 month-4.85%
3 months+1.44%
6 months+3.64%
Current year-1.33%
More quotes
1 week
87.04
Extreme 87.04
90.07
1 month
87.04
Extreme 87.04
94.47
Current year
84.93
Extreme 84.93
96.50
1 year
80.60
Extreme 80.6
104.32
3 years
76.45
Extreme 76.45
106.66
5 years
67.65
Extreme 67.65
106.66
10 years
62.50
Extreme 62.5
106.66
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 31/08/19
Chief Operating Officer 40 31/12/21
Chief Tech/Sci/R&D Officer 51 -
Members of the board TitleAgeSince
Director/Board Member 70 30/04/14
Director/Board Member 62 27/04/20
Director/Board Member 64 21/05/20
More insiders
Date Price Change Volume
30/05/24 88.57 +0.98% 850,720
29/05/24 87.71 -0.98% 1,193,241
28/05/24 88.58 -1.42% 961,541
27/05/24 89.86 +0.38% 500,305
24/05/24 89.52 -0.71% 911,282

Real-time Euronext Paris, May 30, 2024 at 04:37 pm

More quotes
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
88.57 EUR
Average target price
108.2 EUR
Spread / Average Target
+22.15%
Consensus